The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire

S. Tabolli, A. Mozzetta, V. Antinone, S. Alfani, G. Cianchini, D. Abeni

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: Pemphigus vulgaris and pemphigus foliaceus are rare, potentially life-threatening, autoimmune disorders characterized by antibodies to epidermal adhesion molecules. Clinical characteristics are painful chronic erosions of mucous membranes and of the skin. There are only few published studies on the impact of the disease on the health status (HS) of patients with these conditions. Objectives: To assess the impact of disease on the HS of patients with pemphigus. Methods: Fifty-eight patients enrolled at the Bullous Skin Diseases Unit of IDI-IRCCS in the period January-June 2006 were assessed for their HS using the Medical Outcomes Study 36-item short form health survey (SF-36) questionnaire and for anxiety and depression using the Institute for Personality and Ability Testing questionnaires. Results: A compromised HS on both the physical and the psychosocial scales was observed, similar to other chronic dermatological diseases such as psoriasis. Patients with anxiety had severe disease as measured by the Physician's Global Assessment and the degree of mucocutaneous involvement, as well as those with a more recent disease onset. A better HS was observed in patients whose clinical condition was rated as nonsevere, and also in patients with pemphigus foliaceus. In pemphigus vulgaris, antidesmoglein 3 antibody levels directly correlated with clinical severity and with lower SF-36 scores. Conclusions: HS evaluated with the SF-36 can be a very useful additional outcome criterion in clinical studies with pemphigus. The management of the disease must take into account its impact on various aspects of life of the patient.

Original languageEnglish
Pages (from-to)1029-1034
Number of pages6
JournalBritish Journal of Dermatology
Volume158
Issue number5
DOIs
Publication statusPublished - May 2008

Fingerprint

Pemphigus
Health Surveys
Health Status
Outcome Assessment (Health Care)
Health
Anxiety
Vesiculobullous Skin Diseases
Aptitude
Antibodies
Disease Management
Surveys and Questionnaires
Psoriasis
Personality
Mucous Membrane
Chronic Disease
Depression
Physicians
Skin

Keywords

  • Depression
  • Health status
  • Pemphigus
  • SF-36

ASJC Scopus subject areas

  • Dermatology

Cite this

The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire. / Tabolli, S.; Mozzetta, A.; Antinone, V.; Alfani, S.; Cianchini, G.; Abeni, D.

In: British Journal of Dermatology, Vol. 158, No. 5, 05.2008, p. 1029-1034.

Research output: Contribution to journalArticle

@article{3cf273ed21f64c14882295d15c5c0228,
title = "The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire",
abstract = "Background: Pemphigus vulgaris and pemphigus foliaceus are rare, potentially life-threatening, autoimmune disorders characterized by antibodies to epidermal adhesion molecules. Clinical characteristics are painful chronic erosions of mucous membranes and of the skin. There are only few published studies on the impact of the disease on the health status (HS) of patients with these conditions. Objectives: To assess the impact of disease on the HS of patients with pemphigus. Methods: Fifty-eight patients enrolled at the Bullous Skin Diseases Unit of IDI-IRCCS in the period January-June 2006 were assessed for their HS using the Medical Outcomes Study 36-item short form health survey (SF-36) questionnaire and for anxiety and depression using the Institute for Personality and Ability Testing questionnaires. Results: A compromised HS on both the physical and the psychosocial scales was observed, similar to other chronic dermatological diseases such as psoriasis. Patients with anxiety had severe disease as measured by the Physician's Global Assessment and the degree of mucocutaneous involvement, as well as those with a more recent disease onset. A better HS was observed in patients whose clinical condition was rated as nonsevere, and also in patients with pemphigus foliaceus. In pemphigus vulgaris, antidesmoglein 3 antibody levels directly correlated with clinical severity and with lower SF-36 scores. Conclusions: HS evaluated with the SF-36 can be a very useful additional outcome criterion in clinical studies with pemphigus. The management of the disease must take into account its impact on various aspects of life of the patient.",
keywords = "Depression, Health status, Pemphigus, SF-36",
author = "S. Tabolli and A. Mozzetta and V. Antinone and S. Alfani and G. Cianchini and D. Abeni",
year = "2008",
month = "5",
doi = "10.1111/j.1365-2133.2008.08481.x",
language = "English",
volume = "158",
pages = "1029--1034",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Blackwell Publishing Ltd",
number = "5",

}

TY - JOUR

T1 - The health impact of pemphigus vulgaris and pemphigus foliaceus assessed using the Medical Outcomes Study 36-item short form health survey questionnaire

AU - Tabolli, S.

AU - Mozzetta, A.

AU - Antinone, V.

AU - Alfani, S.

AU - Cianchini, G.

AU - Abeni, D.

PY - 2008/5

Y1 - 2008/5

N2 - Background: Pemphigus vulgaris and pemphigus foliaceus are rare, potentially life-threatening, autoimmune disorders characterized by antibodies to epidermal adhesion molecules. Clinical characteristics are painful chronic erosions of mucous membranes and of the skin. There are only few published studies on the impact of the disease on the health status (HS) of patients with these conditions. Objectives: To assess the impact of disease on the HS of patients with pemphigus. Methods: Fifty-eight patients enrolled at the Bullous Skin Diseases Unit of IDI-IRCCS in the period January-June 2006 were assessed for their HS using the Medical Outcomes Study 36-item short form health survey (SF-36) questionnaire and for anxiety and depression using the Institute for Personality and Ability Testing questionnaires. Results: A compromised HS on both the physical and the psychosocial scales was observed, similar to other chronic dermatological diseases such as psoriasis. Patients with anxiety had severe disease as measured by the Physician's Global Assessment and the degree of mucocutaneous involvement, as well as those with a more recent disease onset. A better HS was observed in patients whose clinical condition was rated as nonsevere, and also in patients with pemphigus foliaceus. In pemphigus vulgaris, antidesmoglein 3 antibody levels directly correlated with clinical severity and with lower SF-36 scores. Conclusions: HS evaluated with the SF-36 can be a very useful additional outcome criterion in clinical studies with pemphigus. The management of the disease must take into account its impact on various aspects of life of the patient.

AB - Background: Pemphigus vulgaris and pemphigus foliaceus are rare, potentially life-threatening, autoimmune disorders characterized by antibodies to epidermal adhesion molecules. Clinical characteristics are painful chronic erosions of mucous membranes and of the skin. There are only few published studies on the impact of the disease on the health status (HS) of patients with these conditions. Objectives: To assess the impact of disease on the HS of patients with pemphigus. Methods: Fifty-eight patients enrolled at the Bullous Skin Diseases Unit of IDI-IRCCS in the period January-June 2006 were assessed for their HS using the Medical Outcomes Study 36-item short form health survey (SF-36) questionnaire and for anxiety and depression using the Institute for Personality and Ability Testing questionnaires. Results: A compromised HS on both the physical and the psychosocial scales was observed, similar to other chronic dermatological diseases such as psoriasis. Patients with anxiety had severe disease as measured by the Physician's Global Assessment and the degree of mucocutaneous involvement, as well as those with a more recent disease onset. A better HS was observed in patients whose clinical condition was rated as nonsevere, and also in patients with pemphigus foliaceus. In pemphigus vulgaris, antidesmoglein 3 antibody levels directly correlated with clinical severity and with lower SF-36 scores. Conclusions: HS evaluated with the SF-36 can be a very useful additional outcome criterion in clinical studies with pemphigus. The management of the disease must take into account its impact on various aspects of life of the patient.

KW - Depression

KW - Health status

KW - Pemphigus

KW - SF-36

UR - http://www.scopus.com/inward/record.url?scp=42049098204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049098204&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2133.2008.08481.x

DO - 10.1111/j.1365-2133.2008.08481.x

M3 - Article

C2 - 18294312

AN - SCOPUS:42049098204

VL - 158

SP - 1029

EP - 1034

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

IS - 5

ER -